173 related articles for article (PubMed ID: 22454488)
21. Adverse reactions to voriconazole.
Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
[TBL] [Abstract][Full Text] [Related]
22. Voriconazole in the treatment of invasive fungal infections.
Keady S; Thacker M
Intensive Crit Care Nurs; 2005 Dec; 21(6):370-3. PubMed ID: 15985371
[TBL] [Abstract][Full Text] [Related]
23. The safety of voriconazole.
Potoski BA; Brown J
Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
[No Abstract] [Full Text] [Related]
24. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM
Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928
[TBL] [Abstract][Full Text] [Related]
25. [Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
Papy E; Carde A; Ribaud P; Faure P; Touratier S
Presse Med; 2006 Feb; 35(2 Pt 1):251-2. PubMed ID: 16493359
[No Abstract] [Full Text] [Related]
26. Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.
Brunel AS; Fraisse T; Lechiche C; Pinzani V; Mauboussin JM; Sotto A
AIDS; 2008 Apr; 22(7):905-6. PubMed ID: 18427212
[No Abstract] [Full Text] [Related]
27. Pseudoporphyria associated with voriconazole.
Kwong WT; Hsu S
J Drugs Dermatol; 2007 Oct; 6(10):1042-4. PubMed ID: 17966183
[TBL] [Abstract][Full Text] [Related]
28. Pharmacoeconomics of voriconazole in the management of invasive fungal infections.
Al-Badriyeh D; Heng SC; Neoh CF; Slavin M; Stewart K; Kong DC
Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):623-36. PubMed ID: 21155694
[TBL] [Abstract][Full Text] [Related]
29. High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
Rondeau S; Couderc L; Dominique S; Pramil S; Leguillon C; Masseline B; Favennec L; Marguet C
Eur Respir J; 2012 Mar; 39(3):782-4. PubMed ID: 22379155
[No Abstract] [Full Text] [Related]
30. Voriconazole therapy in children with cystic fibrosis.
Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
[TBL] [Abstract][Full Text] [Related]
31. [Careful: skins cancers and voriconazole].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2011 Nov; 138(11):805-6. PubMed ID: 22078051
[No Abstract] [Full Text] [Related]
32. Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity.
Miller DD; Cowen EW; Nguyen JC; McCalmont TH; Fox LP
Arch Dermatol; 2010 Mar; 146(3):300-4. PubMed ID: 20083676
[TBL] [Abstract][Full Text] [Related]
33. Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients.
Conlon JD; Dauenhauer M; Tonkovic-Capin V; Talano J; Margolis D; Drolet BA; Fairley JA
J Am Acad Dermatol; 2008 Mar; 58(3):484-7. PubMed ID: 18280346
[TBL] [Abstract][Full Text] [Related]
34. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
[TBL] [Abstract][Full Text] [Related]
35. Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
den Hollander JG; van Arkel C; Rijnders BJ; Lugtenburg PJ; de Marie S; Levin MD
J Antimicrob Chemother; 2006 Jun; 57(6):1248-50. PubMed ID: 16556632
[TBL] [Abstract][Full Text] [Related]
36. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
[TBL] [Abstract][Full Text] [Related]
37. Voriconazole in newborns.
Kohli V; Taneja V; Sachdev P; Joshi R
Indian Pediatr; 2008 Mar; 45(3):236-8. PubMed ID: 18367773
[TBL] [Abstract][Full Text] [Related]
38. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Vadnerkar A; Nguyen MH; Mitsani D; Crespo M; Pilewski J; Toyoda Y; Bermudez C; Kwak EJ; Silveira FP; Clancy CJ
J Heart Lung Transplant; 2010 Nov; 29(11):1240-4. PubMed ID: 20591690
[TBL] [Abstract][Full Text] [Related]
39. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
Wermers RA; Cooper K; Razonable RR; Deziel PJ; Whitford GM; Kremers WK; Moyer TP
Clin Infect Dis; 2011 Mar; 52(5):604-11. PubMed ID: 21239842
[TBL] [Abstract][Full Text] [Related]
40. Phototoxicity and photocarcinogenesis associated with voriconazole.
Epaulard O; Leccia MT; Blanche S; Chosidow O; Mamzer-Bruneel MF; Ravaud P; Thiebaut A; Villier C; Lortholary O
Med Mal Infect; 2011 Dec; 41(12):639-45. PubMed ID: 22055586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]